These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29615444)

  • 1. Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial.
    Haines RH; Thomas KS; Montgomery AA; Ravenscroft JC; Akram P; Chalmers JR; Whitham D; Duley L; Eleftheriadou V; Meakin G; Mitchell EJ; White J; Rogers A; Sach T; Santer M; Tan W; Hepburn T; Williams HC; Batchelor J
    BMJ Open; 2018 Apr; 8(4):e018649. PubMed ID: 29615444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial.
    Thomas KS; Batchelor JM; Akram P; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Sach TH; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell NJ; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):828-839. PubMed ID: 33006767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy).
    Eleftheriadou V; Thomas K; Ravenscroft J; Whitton M; Batchelor J; Williams H
    Trials; 2014 Feb; 15():51. PubMed ID: 24507484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An economic evaluation of the randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo (the HI-Light Vitiligo Trial).
    Sach TH; Thomas KS; Batchelor JM; Perways A; Chalmers JR; Haines RH; Meakin GD; Duley L; Ravenscroft JC; Rogers A; Santer M; Tan W; White J; Whitton ME; Williams HC; Cheung ST; Hamad H; Wright A; Ingram JR; Levell N; Goulding JMR; Makrygeorgou A; Bewley A; Ogboli M; Stainforth J; Ferguson A; Laguda B; Wahie S; Ellis R; Azad J; Rajasekaran A; Eleftheriadou V; Montgomery AA;
    Br J Dermatol; 2021 May; 184(5):840-848. PubMed ID: 32920824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The UPDATE trial (UVB Phototherapy in Dermatology for ATopic Eczema): study protocol for a randomized controlled trial of narrowband UVB with optimal topical therapy versus optimal topical therapy in patients with atopic eczema.
    Knöps E; Spuls P; Duijnhoven R; Dijkgraaf M; van Barreveld M; Arents B; van Enst A; Garritsen F; Merkus M; Middelkamp-Hup P; Musters A; Bosma A; Hyseni A; Dijkstra J; Hijnen DJ; Gerbens L
    Trials; 2024 Jul; 25(1):482. PubMed ID: 39014498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
    Khullar G; Kanwar AJ; Singh S; Parsad D
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UVB phototherapy in an outpatient setting or at home: a pragmatic randomised single-blind trial designed to settle the discussion. The PLUTO study.
    Koek MB; Buskens E; Steegmans PH; van Weelden H; Bruijnzeel-Koomen CA; Sigurdsson V
    BMC Med Res Methodol; 2006 Aug; 6():39. PubMed ID: 16882343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Home vs hospital narrowband UVB treatment by a hand-held unit for new-onset vitiligo: A pilot randomized controlled study.
    Liu B; Sun Y; Song J; Wu Z
    Photodermatol Photoimmunol Photomed; 2020 Jan; 36(1):14-20. PubMed ID: 31206787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
    Bakis-Petsoglou S; Le Guay JL; Wittal R
    Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Band-pass Filter Cream (TBFC)-assisted home-based NB-UVB: A must-know Alternative to artificial phototherapy.
    Sonthalia S
    J Cosmet Dermatol; 2021 Jul; 20(7):2141-2147. PubMed ID: 33977652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo--a multicentre controlled study.
    Casacci M; Thomas P; Pacifico A; Bonnevalle A; Paro Vidolin A; Leone G
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):956-63. PubMed ID: 17659006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of 308-nm Monochromatic Excimer Lamp Versus Other Phototherapy Devices for Vitiligo: A Systematic Review with Meta-Analysis.
    Lopes C; Trevisani VF; Melnik T
    Am J Clin Dermatol; 2016 Feb; 17(1):23-32. PubMed ID: 26520641
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.